|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-I integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals显示文摘 | Dejesus E Berger D Markowitz M | 2006 | J Acquir Immune Defic Syndr2006，43，1： | 1 |
| 2 | The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘 | International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M | 2010 | Science2010，330，6010： | 1 |
| 3 | Gastrointestinal tract colonization with Vancomycin-resistant Enterococcus faecium in an animal model显示文摘 | Pitsakis P G Dejesus E | 1996 | Antimcrob Agents Chemother1996，40，： | 1 |
| 4 | The 3-year renal safe- ty of a tenofovir disoproxil fumarate vs a thymidine analogue-containing regimen in antiretroviral-naive patients 显示文摘 | Gallant JE Winston JA DeJesus E etal | 2008 | AIDS2008，22，16： | 1 |
| 5 | Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopi- navir/ritonavir in HIV-l-infected treatment-naYve patients in the ARTEMIS trial显示文摘 | Orkin C DeJesus E Khanlnu H | 2013 | HIV Med2013，14，1： | 1 |
| 6 | Efficacy and safety of once- daily darunavir/ritonavir versus lopinavir/ritonavir in treatment- naive HIV-l-infected patients at week 48 显示文摘 | Ortiz R Dejesus E Khanlou H | 2008 | AIDS2008，22，12： | 1 |
| 7 | Antiviral activity,pharmacokinetics,and dose response of the HIV-1 integrase inhibitor GS-9137(JTK-303) in treatment-naive and treatment-experienced patients显示文摘 | DeJesus E Berger D Markowitz M | 2006 | J Acquir Immune Defic Syndr2006，43，1： | 1 |
| 8 | Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regi mens improves fasting lipid profiles, maintains virologic suppres- sion, and simplifies treatment显示文摘 | Keiser PH Sension MG DeJesus E | 2005 | BMC Infect Dis2005，5，： | 1 |
| 9 | Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infeeted adults显示文摘 | Dejesus E Herrera G Teofilo E | 2004 | Cin Infect Dis2004，39，7： | 1 |
| 10 | Co-formulated elvitegra- vir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and teno- fovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomized, double-blind, phase 3, non-inferiority trial显示文摘 | DeJesus E Rockstroh JK Henry K | 2012 | Lancet2012，379，9835： | 1 |
| 11 | Association betweenrepeat sizes and clinical and pathological characteristics incarriers of C90RF72 repeat expansions(Xpansize 72) : a crosssectional cohort study 显示文摘 | VAN BM DEJESUS HM NIE E | 2013 | Lancet Neurol2013，12，10： | 1 |
| 12 | A randomized, double- blind comparison of eoformulated elvitegravir/eobieistat/emtrieit- abine/tenofovir DF vs ritonavir-boosted atazanavir plus eoformulated emtricitabine and tenofovir DF for initial treatment of HIV-I infection : analysis of week 96 results显示文摘 | Reckstroh JK DeJesus E Henry K | 2013 | J Acquir Immune Defic Syndr2013，62，5： | 1 |
| 13 | Efficacy and safety of once-daily darunavir/ritonavir versus lopi- navir/ritonavir in treatment-naive HIV-l-infected patients at week 48显示文摘 | Ortiz R Dejesus E Khanlou H | 2008 | AIDS2008，22，12： | 1 |
| 14 | Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV -1-infected patients at week 48显示文摘 | Ortiz R Dejesus E Khanlou H | 2008 | AIDS2008，22，12： | 1 |
| 15 | Adherence to enfuvirtide and its impact on treatment efficacy显示文摘 | Rockstroh J Dejesus E Donatacci L | 2008 | AIDS Rcs Hum Retroviruses2008，24，2： | 1 |
| 16 | Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: Results of the ziagen once daily in antiretroviral combination study显示文摘 | Moyle GJ Dejesus E Cahn P | 2005 | J Acquir Immune Defic Syndr2005，38，4： | 1 |
| 17 | Abacavir and lamivudine fixed-dose combination tablet once-daily compared with abaeavir and lamivudine twice-daily in HIV-1 infected patients over 48 weeks (ESS30008, SEAL) 显示文摘 | Sosa N Hill-Zabala C Dejesus E | 2005 | J Acquir Immune Defic Syndr2005，40，4： | 1 |
| 18 | Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection : a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks 显示文摘 | Sax PE Dejesus E Mills A | 2012 | Lancet2012，379，9835： | 1 |
| 19 | Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus -infected显示文摘 | Dejesus E Wald A Warren T | 2003 | J Infect Dis2003，188，： | 1 |
| 20 | Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a muhicen- tre, double-blind randomised controlled trial显示文摘 | Lennox JL Dejesus E Lazzarin A | 2009 | Lancet2009，374，9692： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员